It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patients Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA Swedish study expands range of airborne toxics associated with rheumatic disease Dec 06, 2022
Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs Benefit seen with conventional DMARDs as well as biologics Dec 02, 2022
Common Treatments for Knee Osteoarthritis May Be Harmful Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
Study: New Moms Need Not Worry About Enbrel in Breast Milk Present in small amounts, but infants apparently unaffected in small sample Nov 28, 2022
Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
Two Surgery Types Yield Similar Results in Advanced Ankle Osteoarthritis Similar clinical scores with either total ankle replacement or fusion surgery, trial shows Nov 14, 2022
Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
For Better COVID Vax Response in Rheumatology Patients, Hold the MMF Longer Small study suggests at least a 10-day holiday Nov 14, 2022
Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
Safer Alternative to Cyclophosphamide at Hand for ILD? Drug targeting B cells as effective as broad-spectrum immunosuppressant in lung disease Nov 14, 2022
Novel BTK Inhibitor Looks Good for Sjogren's Syndrome Phase II data show good efficacy by objective measures, even with strong placebo effect Nov 13, 2022
ANCA-Associated Vasculitis: Novel Biologic Shows Promise for Replacing Steroids Small trial demonstrates big cut in steroid-linked adverse effects Nov 13, 2022
Twelve-Month Data Back Pegloticase-Methotrexate Gout Combo More support for add-on methotrexate to maintain protein drug's efficacy Nov 13, 2022
Want a Few Weeks of Knee Pain Relief? Try This Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
Sjogren's Responds to Cytokine Treatment, Early Data Show Phase II trial signals possible breakthrough for hard-to-treat illness Nov 10, 2022
Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
New ACR/EULAR Guideline Expands RA Remission Definition Axial spondyloarthritis guidance also gets an update Oct 25, 2022
Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
Notes From Underground: Miners Face Increased Risk of Rheumatoid Arthritis Silica exposure seen responsible Oct 17, 2022
What Caused Left-Sided Hearing Loss in This 65-Year-Old Man? Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear Oct 03, 2022
Have We Been Overcautious With TNF Inhibitors in Pregnancy? Study of IBD patients finds no basis for common practice Sep 26, 2022
Is PMR the Next Indication for Tocilizumab? Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
Data Now Out for Pegloticase-MTX Combo Gout Treatment Journal publication supports recent label change Sep 16, 2022
Is Cancer Therapy Also a Lupus Cure? Patients in pilot study show months-long complete remission Sep 15, 2022
Confirmed: Gout Comes With Increased Heart Risk But associated conditions (like obesity) still play largest role Sep 13, 2022
Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
Good News, Bad News for Global Hip Fracture Rates Incidence has declined, but burden will increase as older population grows Sep 10, 2022
Mixed Results for Novel Lupus Drug in Mid-Stage Trial Developer of litifilimab, an anti-BDCA2 antibody, presses ahead despite phase II hiccups Sep 07, 2022
Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
Xarelto Risky in Rheumatic Heart Disease Ischemic event prevention didn't pan out in INVICTUS trial Aug 28, 2022
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis But is Russian backing a problem for U.S. approval? Aug 24, 2022
Do We Need to Worry About Low Serum Urate? Study may have found answer to long-standing question Aug 19, 2022
Organ Damage in Lupus: Some Ethnicities Bear More Burden Than Others Results from California cohort mirror epidemiology of lupus itself Aug 16, 2022
Once the 'Disease of Kings,' Gout Now Reigns Through Poverty, Disparity National data outlines factors behind racial and sex-based disparities Aug 15, 2022
Study: Flares in Pustular Psoriasis Often Undertreated Drug firm hopes to bring new specific treatment to market Aug 10, 2022
